Ji. Iglesias et al., The natural history of incidental renal artery stenosis in patients with aortoiliac vascular disease, AM J MED, 109(8), 2000, pp. 642-647
Citations number
50
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
PURPOSE: To examine the association between incidentally discovered renal a
rtery stenosis and deterioration of renal function as determined by the cha
nge in serum creatinine concentration over time.
SUBJECTS AND METHODS: We performed a retrospective review of consecutive pa
tients who underwent aortography for aortoiliac vascular disease. Angiogram
s were reviewed for renal artery stenosis, defined as a narrowing of at lea
st 20% compared with adjacent normal renal artery. For patients with at lea
st 180 days of subsequent follow-up, the change in serum creatinine concent
ration per year was compared in patients who had or did not have renal arte
ry stenosis.
RESULTS: Of the 201 patients, 96 (48%) had some degree of renal artery sten
osis in one or both renal arteries, including 53 (26%) who had at least one
stenosis greater than or equal to 50% and 40 (20%) who had bilateral steno
ses. The only clinical predictor of renal artery stenosis was a history of
coronary artery disease (odds ratio = 2.0, 95% confidence interval: 1.2 to
3.8, P = 0.001). Among the 174 patients with greater than or equal to 180 d
ays of follow-up, there was no statistically significant difference (P = 0.
88) in the mean change in serum creatinine concentration per year in the 78
patients with renal artery stenosis (0.06 +/- 0.33 mg/dL per year) as comp
ared with the 96 patients without renal artery stenosis (0.06 +/- 0.22 mg/d
L per year). Grouping the patients by the maximal percentage of stenosis di
d not reveal any difference in the mean changes in serum creatinine concent
ration per year.
CONCLUSIONS: Although renal artery stenosis is a common incidental finding
in patients with atherosclerotic vascular disease, it is an uncommon cause
of progressive renal disease. (C) 2000 by Excerpta Medica, Inc.